CIRX — CirTran Income Statement
0.000.00%
Last trade - 00:00
- $0.08m
- $6.29m
- $1.72m
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 1.73 | 2.92 | 1.72 |
Cost of Revenue | |||||
Gross Profit | 0 | 0 | 0.544 | 1.4 | 0.482 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 0.447 | 0.406 | 0.631 | 3.07 | 2.24 |
Operating Profit | -0.447 | -0.406 | 1.1 | -0.143 | -0.522 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.946 | -1.08 | 0.453 | -0.838 | -1.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.946 | -1.08 | 0.453 | -0.838 | -1.35 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -1.11 | -1.23 | 0.532 | 0.126 | -1.5 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1.11 | -1.23 | 0.532 | 0.126 | -1.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.21 | -0.24 | -0.003 | -0.189 | -0.273 |